Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation

Transplantation

Volumn 90, Issue 8, 2010, Pages 918-926

  Cho, Byung Sik ^a   Yahng, Seung Ah ^a   Lee, Sung Eun ^a   Eom, Ki Seong ^a   Kim, Yoo Jin ^a   Kim, Hee Je ^a   Lee, Seok ^a   Min, Chang Ki ^a   Cho, Seok Goo ^a   Kim, Dong Wook ^a   Lee, Jong Wook ^a   Min, Woo Sung ^a   Park, Chong Won ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Consensus criteria; Thrombotic microangiopathy

Indexed keywords

ALTEPLASE; CYCLOSPORIN; DEFIBROTIDE; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC IDIOPATHIC MYELOFIBROSIS; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; COHORT ANALYSIS; CONSENSUS; COOMBS TEST; ERYTHROCYTE DISORDER; FEMALE; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY DYSFUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NEUROLOGIC DISEASE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REDUCED INTENSITY CONDITIONING; SCHISTOCYTOSIS; T CELL DEPLETION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VALIDATION STUDY; ALLOTRANSPLANTATION; BLOOD; CONSENSUS DEVELOPMENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; REPRODUCIBILITY; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET COUNT; REPRODUCIBILITY OF RESULTS; THROMBOCYTOPENIA; THROMBOTIC MICROANGIOPATHIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 78349238830     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f24e8d     Document Type: Article

References (24)

1. Batts ED, Lazarus HM. Diagnosis and treatment of transplantation- associated thrombotic microangiopathy: Real progress or are we still waiting? Bone Marrow Transplant 2007; 40: 709.
2. Choi CM, Schmaier AH, Snell MR, et al. Thrombotic microangiopathy in haematopoietic stem cell transplantation: Diagnosis and treatment. Drugs 2009; 69: 183.
3. George JN, Li X, McMinn JR, et al. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma. Transfusion 2004; 44: 294.
4. Ho VT, Cutler C, Carter S, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 571.
5. Ruutu T, Barosi G, Benjamin RJ, et al. Diagnostic criteria for hemato-poietic stem cell transplant-associated microangiopathy: Results of a consensus process by an International Working Group. Haematologica 2007; 92: 95.
6. Cho BS, Min CK, Eom KS, et al. Clinical impact of thrombotic mi-croangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 813.
7. Kennedy GA, Bleakley S, Butler J, et al. Posttransplant thrombotic mi-croangiopathy: Sensitivity of proposed new diagnostic criteria. Transfusion 2009; 49: 1884.
8. George JN. Hematopoietic stem cell transplantation-associated throm-botic microangiopathy: Defining a disorder. Bone Marrow Transplant 2008; 41: 917.
9. Siami K, Kojouri K, Swisher KK, et al. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: An autopsy study. Transplantation 2008; 85: 22.
10. Zeigler ZR, Shadduck RK, NemunaitisJ,etal. Bone marrow transplant-associated thrombotic microangiopathy: A case series. Bone Marrow Transplant 1995; 15: 247.
11. Daly AS, Xenocostas A, Lipton JH. Transplantation-associated throm-botic microangiopathy: Twenty-two years later. Bone Marrow Transplant 2002; 30: 709.
12. Ruutu T, Hermans J, Niederwieser D, et al. Thrombotic thrombocyto-penic purpura after allogeneic stem cell transplantation:A survey ofthe European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2002; 118: 1112.
13. Kanamori H, Takaishi Y, Takabayashi M, et al. Clinical significance of fragmented red cells after allogeneic bone marrow transplantation. Int J Hematol 2003; 77: 180.
14. Martinez MT, Bucher C, Stussi G, et al. Transplant-associated mi-croangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant 2005; 36: 993.
15. Shimoni A, Yeshurun M,HardanI,et al. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era ofreduced-intensity conditioning: The incidence is not reduced. Biol Blood Marrow Transplant 2004; 10: 484.
16. Couriel DR, Saliba R, Escalón MP, et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol 2005; 130: 409.
17. Couriel DR, Saliba R, Escalón MP, et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hemato-poietic stem cell transplantation. Transplantation 2006; 82: 638.
18. Min CK, Kim DW, Lee JW, et al. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia: Reduction of graft failure by enhancing stem cell dose. Haematologica 2001; 86: 303.
19. Kim HJ, Park CY, Park YH, et al. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplas-tic anemia patients. Bone Marrow Transplant 2003; 31: 79.
20. Lee S, Kim YJ, Min CK, et al. The effect of first-line imatinib interim therapyonthe outcomeofallogeneic stem cell transplantationinadults with newly diagnosed Philadelphia chromosome-positive acute lym-phoblastic leukemia. Blood 2005; 105: 3449.
21. Min CK, Kim SY, Lee MJ, et al. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 38: 149.
22. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825.
23. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215.
24. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141.